article thumbnail

Reimagining CLM’s Role in the Biopharmaceutical Space

SirionLabs

According to researchers at Tufts University’s Center for the Study of Drug Development, there has been a hefty increase in the total number of procedures across trial phases ; a 69% growth in Phase II and a 49% growth in Phase III.

article thumbnail

Reimaging CLM’s Role in the Biopharmaceutical Space

SirionLabs

According to researchers at Tufts University’s Center for the Study of Drug Development, there has been a hefty increase in the total number of procedures across trial phases ; a 69% growth in Phase II and a 49% growth in Phase III. Outsourcing to Manage the Inherent Complexity of Clinical Trials.